MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
240.31%
Quick Ratio
181.53%
Cash Ratio
107.40%
Debt to Asset Ratio
81.18%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Trade receivable, net
    • Goodwill, ending balance
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Ordinary share of nis 1.75 par v...
    • Others
Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
11,422
2,169
1,956
5,139
Restricted cash
10
240
234
214
Represents the amount of clinical trial services asset current
366
-
-
-
Trade receivable, net
5,664
6,138
6,126
5,864
Prepaid expenses and other current assets
1,844
1,528
1,919
1,871
Inventories
6,251
5,732
7,111
7,622
Assets, current
25,557
15,807
17,346
20,710
Other assets, noncurrent
436
209
205
228
Prepaid expense and other assets, noncurrent
609
-
-
-
Operating lease right-of-use assets
1,491
1,544
221
354
Property, plant and equipment, gross
-
7,896
-
-
Accumulated depreciation
-
7,311
-
-
Property and equipment, net
571
585
641
730
Goodwill, ending balance
4,755
4,755
4,755
4,755
Assets, noncurrent
7,862
7,093
5,822
6,067
Assets
33,419
22,900
23,168
26,777
Trade payables
6,376
5,590
5,251
6,113
Employees and payroll accruals
1,285
1,442
1,252
1,174
Deferred revenues
966
920
1,164
1,166
Convertible notes payable, current
0
2,803
-
-
Less current maturities of operating leases
425
425
149
296
Represent the amount of earnout liability current
-
0
0
0
Other liabilities, current
1,583
859
1,237
1,611
Liabilities, current
10,635
12,039
9,053
10,360
Convertible notes payable, noncurrent
7,276
-
-
-
Derivative liability, noncurrent
6,842
-
-
-
Deferred revenue, noncurrent
1,208
1,233
1,209
1,177
Non-current operating leases
1,113
1,159
88
79
Other current liabilities
54
61
63
51
Liabilities, noncurrent
16,493
2,453
1,360
1,307
Ending balance
27,128
14,492
10,413
11,667
Ordinary share of nis 1.75 par value-authorized 25,000,000 shares at december 31, 2024 and 17,142,857 at december 31, 2023 issued 9,382,801 and 9,161,798 shares at december 31, 2024 and december 31, 2023, respectively outstanding 8,808,143 and 8,587,140 shares as of december 31, 2024 and december 31, 2023 respectively
9,418
9,418
8,652
8,025
Additional paid-in capital
295,608
286,932
286,697
286,509
Treasury shares at cost, 47,888 ordinary shares at march 31, 2026 and december 31, 2025
3,203
3,203
3,203
3,203
Accumulated deficit
-295,532
-284,739
-279,391
-276,221
Balance
6,291
8,408
12,755
15,110
Liabilities and equity
33,419
22,900
23,168
26,777
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$11,422K Inventories$6,251K Trade receivable, net$5,664K Prepaid expenses andother current assets$1,844K Represents the amount ofclinical trial services...$366K Restricted cash$10K Goodwill, ending balance$4,755K Operating leaseright-of-use assets$1,491K Prepaid expense andother assets,...$609K Property and equipment,net$571K Other assets,noncurrent$436K Assets, current$25,557K Assets, noncurrent$7,862K Assets$33,419K Liabilities and equity$33,419K Ending balance$27,128K Balance$6,291K Accumulated deficit-$295,532K Treasury shares at cost,47,888 ordinary shares...$3,203K Liabilities, noncurrent$16,493K Liabilities, current$10,635K Additional paid-in capital$295,608K Ordinary share of nis 1.75par...$9,418K Convertible notes payable,noncurrent$7,276K Derivative liability,noncurrent$6,842K Deferred revenue,noncurrent$1,208K Non-current operatingleases$1,113K Other currentliabilities$54K Trade payables$6,376K Other liabilities,current$1,583K Employees and payrollaccruals$1,285K Deferred revenues$966K Less currentmaturities of operating...$425K

Lifeward Ltd. (LFWD)

Lifeward Ltd. (LFWD)